Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) HKSE

53.00

+1.35(+2.61%)

Updated at September 08 04:08PM

Currency In HKD

Valuation

Market Cap25.02B
Enterprise Value25.6B
P/E Ratio189.47
PEG Ratio-18.47
Price/Sales Ratio7.56
Price/Book Ratio2.73
Enterprise/Revenue7.66
Enterprise/EBITDA99.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.05
Operating Margin0.06

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue6.6B
Revenue/Share7.71
Gross Profit2.24B
EBITDA1.13B
Net Income405.14M
Diluted EPS0.47

Balance Sheet

Total Cash1.82B
Total Cash/Share2.16
Total Debt2.38B
Total Debt/Equity0.12
Current Ratio1.83
Book Value Per Share28.45

Price History

52-Week Change89.95
52-Week High60.6
52-Week Low22.3
Moving Average 50 Days50.08
Moving Average 200 Days36.23

Statistics

Average Volume4.54M
Shares Outstanding1.16B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield0.45
Payout Ratio2.87
Last Split FactorN/A
Last Split DateN/A